Prognostic Utility of the HFpEF-ABA Score for HFpEF Patients
Our study demonstrates substantial regional heterogeneity in the prognostic utility of the HFpEF-ABA score among patients with HFpEF enrolled in the TOPCAT trial. The score exhibited strong associations with adverse outcomes in the Russia/Georgia cohort, whereas its prognostic discrimination was attenuated in the Americas cohort. (Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function [TOPCAT]; NCT00094302).
Authors
- Wengen Zhu
- Xi Chen
- Min Ye
- Linjuan Guo
Institutions
- Fujian Medical University (CN)
- Sun Yat-sen University (CN)
- First Affiliated Hospital of Jiangxi Medical College (CN)
- Jiangxi Provincial People's Hospital (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Sanming University (CN)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-02-25
- DOI
- https://doi.org/10.1016/j.jacadv.2026.102632
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00